NY-ESTÉE-LAUDER
The Estée Lauder Companies Inc. (NYSE:EL) announced today that Meridith Webster will join the company in the newly-created role of Executive Vice President, Global Communications and Public Affairs , effective May 17, 2021. Meridith will report jointly to William P. Lauder, Executive Chairman, and Fabrizio Freda, President and Chief Executive Officer. She will also join The Estée Lauder Companies Inc.’s (“ELC”) Executive Leadership Team.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210511005345/en/
Meridith will succeed Alexandra (Alex) Trower as head of Global Communications and Maria Cristina (MC) González Noguera as head of Global Public Affairs. Her appointment follows the news that Alex has made the decision to retire in June after an esteemed career at the company, and that MC was recently tapped for the role of EVP and Chief Communications and Public Affairs Officer at Popular Inc., the Puerto Rico-based global financial services conglomerate.
“Our world-class Global Communications and Public Affairs teams have consistently advanced ahead of the curve against the backdrop of an increasingly complex and rapidly-changing global landscape,” said Fabrizio Freda . “Meridith’s appointment will continue to enable and enhance our delivery of thoughtful, effective communications to our valued global stakeholders as she leads these talented teams to new heights.”
“Meridith’s deep public and private sector experience, coupled with her core values and leadership style, make her uniquely suited to step into this role now,” said William P. Lauder . “I am so proud of the incredible work of our Global Communications and Public Affairs teams and I know they will be in great hands under Meridith’s leadership as she joins our ELC family.”
In this new role, Meridith will lead ELC’s global communications and public affairs strategic agendas to advance and protect its business interests and corporate reputation globally, and strengthen relationships to drive value for key stakeholders. She will serve as a strategic advisor to the ELC’s Executive Leadership Team, the Board of Directors and the Lauder Family on a variety of critical topics.
Meridith will oversee ELC’s Global Communications and Public Affairs teams, elevating the impact of these important functions across the business. She will lead the strategy and delivery of holistic, integrated global communications to advance ELC’s corporate reputation and winning business narrative, while building brand equity and strengthening the platforms that resonate with key audiences internally and externally. She will also lead the global public affairs and stakeholder engagement strategy to further advance ELC’s business goals, build reputation capital and proactively mitigate issues.
Meridith’s deep government experience includes tenures under multiple U.S. presidential administrations. Meridith joins ELC from the Biden White House, where she served as Special Assistant to the President and Chief of Staff to the Domestic Policy Council. At the Obama White House, she served as Senior Advisor to two White House Chiefs of Staff, Rahm Emanuel and Pete Rouse. She also served as Deputy Chief of Staff to Susan Rice, then the U.S. Ambassador to the United Nations. Meridith started her career working at the Clinton White House and the U.S. State Department before earning her J.D. Degree at Georgetown University Law Center.
Prior to serving in the Biden Administration, she served as Vox Media’s first-ever Chief Communications Officer, overseeing strategic and crisis communications and media relations across a growing modern media company, including editorial networks and advertising, studios, and podcasting. She also previously led the Public Affairs practice at Emerson Collective and served as Global Head of Public Affairs at Bloomberg L.P. and Bloomberg Philanthropies where she managed the expansion of the business and established public affairs and communications functions in Washington, New York and globally.
“I am thrilled to be joining The Estée Lauder Companies. Alex and MC each have done a terrific job leading the company’s Global Communications and Public Affairs functions and positioning these talented teams as strategic business partners,” said Meridith Webster . “It is an honor to step into this new role and I am excited to continue building on the successes of these teams in a rapidly-evolving space. I look forward to partnering with Fabrizio, William and the entire Executive Leadership Team to drive the overall success and continued growth of ELC.”
About The Estée Lauder Companies Inc.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, Tommy Hilfiger, M·A·C, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, TOM FORD BEAUTY, Smashbox, Ermenegildo Zegna, AERIN, RODIN olio lusso, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, BECCA, Too Faced and Dr. Jart+.
ELC-C
ELC-L
View source version on businesswire.com: https://www.businesswire.com/news/home/20210511005345/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom